Ultimately, m6A-lncRNAs were used to determine a prognostic model of patients with pancreatic adenocarcinoma based on the expression values of three lncRNAs (AC092171.5, MEG9, and AC002091.1) (Figure 1E). Here, MEG9 is linked to pancreatic adenocarcinoma.